The report will be delivered in 2-3 business days.

Monoclonal Antibodies (MAbS) Global Market Report 2020-30: Covid 19 Impact and Recovery

Starting Price : $ 4000.00 $3200.00 | Pages : 200 | Published : September 2020 | SKU CODE : 7182 | Format :


The monoclonal antibodies (MABS) market consists of sales of monoclonal antibodies and related services. Monoclonal antibodies are used to enhance and suppress immune response in various medical conditions and to treat various diseases such as cancer, cardiovascular and cerebrovascular diseases. This industry includes establishments that produce anti-cancer monoclonal antibodies to prevent metastasis by reducing cell proliferation, immunological monoclonal anti-bodies, neuropharmacological monoclonal anti-bodies, anti-infective monoclonal antibodies (MAbs) and other MAbs for human beings and animals.

The global monoclonal antibodies (mabs) market is expected to decline from $114.6 billion in 2019 to $100.9 billion in 2020 at a compound annual growth rate (CAGR) of -12%. The decline is mainly due to the worldwide supply and demand failures of drugs due to the COVID-19 outbreak. The biologic drug shortages because of an inadequate production of biologics is hampering the market growth. The inadequate or slowed production is due to the restrictions imposed by governments of various countries to shutdown factories or function with minimal staffing to contain the spread of virus and keep the staff safe. The market is then expected to recover and grow at a CAGR of 14.8% from 2021 and reach $198.2 billion in 2023.

North America was the largest region in the monoclonal antibodies market. In 2018, followed by Europe, Asia Pacific and Middle East respectively. This region is expected to remain the largest during the next five years. The monoclonal antibodies market in Middle East is forecasted to register the highest CAGR during 2018-2023.

Increasing prevalence of cost efficient biosimilar monoclonal antibodies are driving the monoclonal antibodies market growth. The biosimilar aim is to curb the increasing healthcare cost and handle economic pressure from the patient pod and governments to reduce cost of medication and increase access to treatment. Biosimilar are the pharmaceuticals that are developed to have similar properties to a biologic drug that has already been approved. A biosimilar monoclonal antibody costs 20%-25% lesser than the originator biologic drug. The number of clinical trials for a biosimilar is comparatively lesser than that of original biologic drug and this proves to be the reason for the low cost of a biosimilar drug. In India, a new biosimilar policy called the ‘Guidelines on Similar Biologics’ prepared by the Central Drugs Standard Control Organization (CSDCO) is expected to give a major boost to the Indian biosimilar drugs industry.

Alternative treatment methods and natural remedies are increasingly becoming popular globally and this is expected to have a negative impact on the revenues of monoclonal antibody drugs market. Treatments in the fields of homeopathy, Ayurveda, yoga, acupuncture, sujok therapy are gaining popularity and slowly replacing some traditional hospital practices. For instance, the revenue of US retail sales of homeopathic and herbal remedies was around $7.5 billion in 2017.  Similarly, traditional and complementary medicine market increased from $199 billion in 2015 to $360 billion in 2017. These less expensive alternatives increase competitiveness for the biologics market putting downward pressure and limiting the demand for monoclonal antibody drugs.

The monoclonal antibodies market has been witnessing multiple strategic initiatives in the recent years. Top companies in the market are strategically acquiring start-ups and mid-sized companies to broaden products and services. Strategic collaborations or acquisitions and partnership agreements help vendors expand their existing product portfolio and geographical reach. For instance, In February 2019, AbCellera and Novartis enter into multi-target partnership to create an antibody drug discovery platform and technology for treating clinically-relevant and neurodegenerative diseases. Furthermore, in 2017, AbCellera collaborated with GlaxoSmithKline (GSK), a pharmaceutical company, for the discovery of monoclonal antibodies against an undisclosed membrane protein target. In November 2015, Merck completed the acquisition of Sigma-Aldrich Corp., a leading life science company. Post this acquisition, Merck has more than 50,000 employees, 72 manufacturing sites, and presence in 67 countries worldwide. Companies in the industry are increasingly realigning their portfolios and pursuing profitable inorganic growth opportunities. Additionally, M&A interest is also being fueled by stronger corporate balance sheets, liquid debt markets, and continued favorable interest rates globally

The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human Services, in the USA regulating the monoclonal antibodies and pharmaceutical drugs market. Increasing product launches and regulatory support for the treatment of rare diseases by USFDA is expected to support the monoclonal antibody therapeutics market growth.  For instance, in 2017, the U.S. Food and Drug Administration (FDA) granted accelerated approval to avelumab (BAVENCIO, EMD Serono, Inc.), a human monoclonal antibody, for the treatment of a rare disease, metastatic Merkel cell carcinoma (MCC). Similarly, in 2017, the U.S FDA granted accelerated approval to immunotherapy product- TECENTRIQ (atezolizumab), a humanized, engineered monoclonal antibody, for the treatment of people with locally-advanced or metastatic urothelial carcinoma (mUC).

The major players covered in the global monoclonal antibodies (MAbS) market are Johnson & Johnson, Merck, AbbVie, Amgen, Glaxosmithkline plc, Norvatis AG, Pfizer Inc, Thermofischer  Scientific, Elililly and Company, Bristol-Myers Squibb, Hoffman Roche Ltd, Sanofi, Abbott Laboratories, Mylan N.V, Novo Nordisk A/S, Daiichi Sankyo Company ltd., Seattle genetics, Teva pharmaceutical industries, Shanghi Junsi bioscience ltd, GenScript, Sigma-Aldrich Co. LLC, AbGenomics, ADC Therapeutics, Agensys, Alexion Pharmaceuticals, ALMAC Group, Ambrx, Astellas Pharma, Celgene, Celldex Therapeutics.

The countries covered in the global monoclonal antibodies (MAbS) market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia.

The regions covered in the global monoclonal antibodies (MAbS) market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global monoclonal antibodies (MAbS) market is segmented - 1) By Source: Murine, Chimeric, Humanized, Human. 2) By Application: Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological, Cardiovascular And Cerebrovascular, Others. 3) By End Users: Hospitals, Private Clinics, Research Institute.

    1. Executive Summary

    2. Monoclonal Antibodies  Market Characteristics

    3. Monoclonal Antibodies  Market Size And Growth

    3.1. Global Monoclonal Antibodies  Historic Market, 2015-2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Monoclonal Antibodies  Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Monoclonal Antibodies  Market Segmentation

    4.1. Global Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Murine

    Chimeric

    Humanized

    Human 

    4.2. Global Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Anti-Cancer

    Immunological

    Anti-Infective Monoclonal Antibodies (MAbs)

    Neuropharmacological

    Cardiovascular And Cerebrovascular

    Others

    4.3. Global Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Hospitals

    Private Clinics

    Research Institute

    5. Monoclonal Antibodies  Market Regional And Country Analysis

    5.1. Global Monoclonal Antibodies  Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global Monoclonal Antibodies  Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Monoclonal Antibodies  Market  

    6.1. Asia-Pacific Monoclonal Antibodies  Market Overview  

    6.2. Asia-Pacific Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6.4. Asia-Pacific Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China Monoclonal Antibodies  Market  

    7.1. China Monoclonal Antibodies  Market Overview  

    7.2. China Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    7.3. China Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    7.4. China Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India Monoclonal Antibodies  Market  

    8.1. India Monoclonal Antibodies  Market Overview  

    8.2. India Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    8.3. India Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    8.4. India Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan Monoclonal Antibodies  Market  

    9.1. Japan Monoclonal Antibodies  Market Overview  

    9.2. Japan Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9.3. Japan Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9.4. Japan Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia Monoclonal Antibodies  Market  

    10.1. Australia Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10.2. Australia Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10.3. Australia Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia Monoclonal Antibodies  Market  

    11.1. Indonesia Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11.2. Indonesia Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11.3. Indonesia Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea Monoclonal Antibodies  Market  

    12.1. South Korea Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12.2. South Korea Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12.3. South Korea Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe Monoclonal Antibodies  Market  

    13.1. Western Europe Monoclonal Antibodies  Market Overview

    13.2. Western Europe Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13.3. Western Europe Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13.4. Western Europe Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK Monoclonal Antibodies  Market  

    14.1. UK Monoclonal Antibodies  Market Overview

    14.2. UK Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14.3. UK Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14.4. UK Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany Monoclonal Antibodies  Market  

    15.1. Germany Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15.2. Germany Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15.3. Germany Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France Monoclonal Antibodies  Market  

    16.5. France Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16.6. France Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16.7. France Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe Monoclonal Antibodies  Market  

    17.1. Eastern Europe Monoclonal Antibodies  Market Overview

    17.2. Eastern Europe Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17.4. Eastern Europe Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia Monoclonal Antibodies  Market  

    18.1. Russia Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18.2. Russia Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18.3. Russia Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America Monoclonal Antibodies  Market  

    19.1. North America Monoclonal Antibodies  Market Overview

    19.2. North America Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19.3. North America Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19.4. North America Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA Monoclonal Antibodies  Market  

    20.1. USA Monoclonal Antibodies  Market Overview

    20.2. USA Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20.3. USA Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20.4. USA Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America Monoclonal Antibodies  Market  

    21.1. South America Monoclonal Antibodies  Market Overview

    21.2. South America Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21.3. South America Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21.4. South America Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil Monoclonal Antibodies  Market  

    22.1. Brazil Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22.2. Brazil Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22.3. Brazil Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East Monoclonal Antibodies  Market  

    23.1. Middle East Monoclonal Antibodies  Market Overview

    23.2. Middle East Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23.3. Middle East Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23.4. Middle East Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa Monoclonal Antibodies  Market  

    24.1. Africa Monoclonal Antibodies  Market Overview

    24.2. Africa Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24.3. Africa Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24.4. Africa Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. Monoclonal Antibodies  Market Competitive Landscape And Company Profiles

    25.1. Monoclonal Antibodies  Market Competitive Landscape

    25.2. Monoclonal Antibodies  Market Company Profiles

    25.2.1. Johnson & Johnson

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Merck

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. AbbVie

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Amgen

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Glaxosmithkline plc

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Monoclonal Antibodies  Market

    27. Monoclonal Antibodies  Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Monoclonal Antibodies  Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2019-2023F, 2025F, 2030F, $ Billion
  • Table 3: Global Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Global Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: China, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: China, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: China, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: India, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: India, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: India, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Japan, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Japan, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: Japan, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: Australia, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: Australia, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: Australia, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: Indonesia, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: Indonesia, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Indonesia, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: South Korea, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 27: South Korea, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 28: South Korea, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 29: Western Europe, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 30: Western Europe, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 31: Western Europe, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 32: UK, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 33: UK, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 34: UK, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 35: Germany, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 36: Germany, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 37: Germany, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 38: France, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 39: France, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 40: France, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 41: Eastern Europe, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 42: Eastern Europe, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 43: Eastern Europe, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 44: Russia, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 45: Russia, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 46: Russia, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 47: North America, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 48: North America, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 49: North America, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 50: USA, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 51: USA, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 52: USA, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 53: South America, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 54: South America, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 55: South America, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 56: Brazil, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 57: Brazil, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 58: Brazil, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 59: Middle East, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 60: Middle East, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 61: Middle East, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 62: Africa, Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 63: Africa, Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 64: Africa, Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 65: Johnson & Johnson Financial Performance
  • Table 66: Merck Financial Performance
  • Table 67: AbbVie Financial Performance
  • Table 68: Amgen Financial Performance
  • Table 69: Glaxosmithkline plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2019-2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global Monoclonal Antibodies  Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Global Monoclonal Antibodies  Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: China, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: China, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: China, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: India, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: India, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: India, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: Japan, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Japan, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: Japan, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: Australia, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: Australia, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: Australia, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: Indonesia, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: Indonesia, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Indonesia, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: South Korea, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 27: South Korea, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 28: South Korea, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 29: Western Europe, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 30: Western Europe, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 31: Western Europe, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 32: UK, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 33: UK, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 34: UK, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 35: Germany, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 36: Germany, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 37: Germany, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 38: France, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 39: France, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 40: France, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 41: Eastern Europe, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 42: Eastern Europe, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 43: Eastern Europe, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 44: Russia, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 45: Russia, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 46: Russia, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 47: North America, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 48: North America, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 49: North America, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 50: USA, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 51: USA, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 52: USA, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 53: South America, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 54: South America, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 55: South America, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 56: Brazil, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 57: Brazil, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 58: Brazil, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 59: Middle East, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 60: Middle East, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 61: Middle East, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 62: Africa, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 63: Africa, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 64: Africa, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 65: Johnson & Johnson Financial Performance
  • Figure 66: Merck Financial Performance
  • Figure 67: AbbVie Financial Performance
  • Figure 68: Amgen Financial Performance
  • Figure 69: Glaxosmithkline plc Financial Performance
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)